The Incidence of Thyroid Cancer Among Breast Cancer Survivors
Jennifer H. Kuo, MD, director, Thyroid Biopsy Program, Columbia University, discusses a study looking at the incidence of thyroid cancer among breast cancer survivors.
Clinical Pearls
Jennifer H. Kuo, MD, director, Thyroid Biopsy Program, Columbia University, discusses a study looking at the incidence of thyroid cancer among breast cancer survivors.
- There is an increased risk for the development of thyroid cancer after having breast cancer. The highest risk is among younger patients.
- Adjuvant radiation therapy plays a role in this phenomenon.
- There were higher proportions of tall cell variant papillary, oxyphilic follicular, and anaplastic thyroid cancers observed after breast cancer in this study. These are more aggressive forms of disease compared with what is seen in the regular population.
Anticipating Novel Options for the RAI-Refractory DTC Armamentarium
May 15th 2023In season 4, episode 6 of Targeted Talks, Warren Swegal, MD, takes a multidisciplinary look at the RAI-refractory differentiated thyroid cancer treatment landscape, including the research behind 2 promising systemic therapy options.
Listen
HER2-Low and -Ultralow Populations Benefit from T-DXd in HR+ mBC
November 13th 2024During a Case-Based Roundtable® event, Aditya Bardia, MD, MS, FASCO, discussed data from the DESTINY-Breast04 and DESTINY-Breast06 trials for HER2-low breast cancer in the second article of a 2-part series.
Read More
